PC-3 prostate carcinoma cells release signal substances that influence the migratory activity of cells in the tumor's microenvironment
© Voss et al; licensee BioMed Central Ltd. 2010
Received: 10 June 2010
Accepted: 13 July 2010
Published: 13 July 2010
Tumor cells interact with the cells of the microenvironment not only by cell-cell-contacts but also by the release of signal substances. These substances are known to induce tumor vascularization, especially under hypoxic conditions, but are also supposed to provoke other processes such as tumor innervation and inflammatory conditions. Inflammation is mediated by two organ systems, the neuroendocrine system and the immune system. Therefore, we investigated the influence of substances released by PC-3 human prostate carcinoma cells on SH-SY5Y neuroblastoma cells as well as neutrophil granulocytes and cytotoxic T lymphocytes, especially with regard to their migratory activity.
PC-3 cells express several cytokines and growth factors including vascular endothelial growth factors, fibroblast growth factors, interleukins and neurotrophic factors. SH-SY5Y cells are impaired in their migratory activity by PC-3 cell culture supernatant, but orientate chemotactically towards the source. Neutrophil granulocytes increase their locomotory activity only in response to cell culture supernantant of hypoxic but not of normoxic PC-3 cells. In contrast, cytotoxic T lymphocytes do not change their migratory activity in response to either culture supernatant, but increase their cytotoxicity, whereas supernatant of normoxic PC-3 cells leads to a stronger increase than that of hypoxic PC-3 cells.
PC-3 cells release several signal substances that influence the behavior of the cells in the tumor's microenvironment, whereas no clear pattern towards proinflammatory or immunosuppressive conditions can be seen.
Today's understanding of the biology of tumors increasingly shows a crucial role of the microenvironment in the tumors' growth and the course of the cancer disease. This environmental interactions concern the development of new blood vessels in tumors (called neoangiogenesis), which was one of the first tumor-stroma interactions described in 1971 by Judah Folkman and colleagues , as well as similarly the development of new lymph vessels (lymphangiogenesis) , and the innervation of tumors, which we have termed neoneurogenesis [3, 4]. Because of strong similarities to tissue growth and regeneration, tumors are regarded as wounds that do not heal . A further argument for a comparison of tumors and wounds is the presence of cells of the immune system as well as fibroblasts infiltrating tumors being redolent of inflammatory conditions. Such parallels have already been observed by Virchow back in 1863, and this hypothesis of a non-healing wound has been seized and refined by Balkwill and Mantovani . An inflammatory milieu is regarded as beneficial for a tumor in several aspects, concerning the growth as well as the migratory activity of tumor cells , which is a prerequisite for invasion and metastasis formation .
Two organ systems provide pro-inflammatory signal substances. Predominantly, there are of course the cells of the immune system, that release cytokines and chemokines which provoke inflammatory effect. However, the immune system is under the superordinate regulation of the nervous system, and the nervous system itself releases substances that play a role in inflammation. Thus, the above mentioned neoneurogenesis - the innervation of tumor tissue - might facilitate pro-inflammatory events in two ways: either directly by the release of neurotransmitters that act on the tumor cells (e.g. substance P, bradykinin, calcitonin gene-related peptide) , or indirectly by an action on leukocytes that release such factors in response.
But what causes the presence of leukocytes and the innervation of a tumor? It is well documented that tumor cells release a plethora of signal substances including chemoattractive molecules . This release is a regulated process, e.g. by hypoxic conditions . The lack of oxygen and nutrition provokes the tumor cells to release substances that initiate the above described three related processes: neoangiogenesis, lymphangiogenesis, and neoneurogenesis . However, most studies on the tumor-environment interactions aim to the understanding of tumor vascularisation, and less attention has been paid to the mechanisms of tumor innervation and leukocyte infiltration. Therefore, we investigated by the use of the prostate carcinoma cell line PC-3 the tumor interactions with cells of the nervous system on the example of SH-SY5Y human neuroblastoma cells and with cells of the immune system on the example of neutrophil granulocytes and cytotoxic T lymphocytes (CTLs), especially with regard to the migratory activity of these cells. Migration is one essential cell function for nerve cells to innervate the tumor and for leukocytes to extravasate from the blood and infiltrate the tumor tissue.
Cell isolation and cell culture
Human CTLs and neutrophil granulocytes were isolated from peripheral blood of voluntary healthy donors as described previously . Heparinized blood was diluted with PBS (1:1.7). Neutrophil granulocytes together with erythrocytes were separated from the lymphocyte-containing peripheral blood mononuclear cell fraction by a density gradient centrifugation on lymphocyte separation medium (LSM 1077; PAA, Pasching, Austria). Subsequently, the neutrophil granulocytes were further isolated from the pellet of the centrifugation. The pellet was mixed with platelet-depleted serum from the same blood donor and diluted by 1:1.3 with a high molecular weight dextran solution (Macrodex; Fresenius, Bad Homburg, Germany) containing 0.01 M EDTA. After 3 hours, the supernatant containing granulocytes was isolated and remaining erythrocytes were removed by a hypotonic lysis with 0.3% sodium chloride on ice. The neutrophil granulocytes were used for experiments immediately after isolation.
The CTLs were positively selected from the mononuclear cell fraction of the density gradient centrifugation by immunomagnetic beads, which were coated with mouse anti-human CD8 monoclonal antibodies (Dynabeads; Invitrogen, Karlsruhe, Germany). The mononuclear cell fraction was incubated with the beads for 10 minutes at 4°C. Bead-bound cells were isolated by eight times washing with Dulbecco's PBS (PAA) in a magnetic field. After that, the beads were removed from the isolated CTL using Detachabeads (Invitrogen) at incubation for 45 minutes at 20°C. The CTLs were kept in culture overnight with RPMI culture medium (PAA) containing 10% heat-inactivated fetal calf serum (PAA) and 1% penicillin/streptomycin solution (50 U/ml and 50 μg/ml, respectively; GIBCO, Eggenstein-Leopoldshafen, Germany) at 37°C in a humidified atmosphere containing 5% CO2.
The isolated CTLs were activated by anti-CD3 and anti-CD28 antibodies (both BD Pharmingen, Erembodegem, Belgium) as described previously . Twenty-four-well plates were coated with 10 μg/ml of each of these antibodies in 1 ml PBS at 4°C over night. Cells were seeded at a concentration of 8 × 105 cells/ml in culture medium as described above. The cells were incubated for three days, with the daily addition of 150 ng/ml IL-2 (Invitrogen, Nivelles, Belgium). Maximum activation of the cells (as measured by the activation markers CD25 and CD45R0) was reached after four days, but the granularity (as measured by the sideward scatter) reached the maximum already after three days and decreased to day four.
PC-3 human prostate carcinoma cells (DSMZ, Braunschweig, Germany) were cultured in HAMs and RPMI medium (1:1) containing 10% heat-inactivated fetal calf serum (PAA) and 1% penicillin/streptomycin solution (50 U/ml and 50 μg/ml, respectively; GIBCO) at 37°C in a humidified atmosphere containing 5% CO2. Hypoxia was induced by a stepwise oxygen-deprivation in hypoxia-chambers (Billups-Rothenberg, Del Mar, CA): PC-3 cells were kept two days at 10% O2, one day at 5% O2, and one day at 1% O2 with constantly 5% CO2 and the remainder being N2.
SH-SY5Y human neuroblastoma cells (ATCC, Rockville, MA) were cultured in DMEM medium (PAA) containing 10% heat-inactivated fetal calf serum (PAA) and 1% penicillin/streptomycin solution (50 U/ml and 50 μg/ml, respectively; GIBCO) at 37°C in a humidified atmosphere containing 5% CO2. The cells were differentiated to fully neurotrophic factor-dependent neuron-like cells by treatment for five days with 10 μM retinoic acid (RA; Sigma-Aldrich, Taufkirchen, Germany) and used for experiments immediately after differentiation.
Cell migration experiments
We performed our conventional three-dimensional, collagen-based migration assay as described in detail previously . In brief, a suspension of 2.5 × 105 leukocytes or 8 × 104 SH-SY5Y cells or PC-3 cells in 50 μl RPMI was mixed with 100 μl of a buffered collagen solution (pH 7.4), containing 1.67 mg/ml bovine collagen type I (Invitrogen, Cohesion Technologies, Palo Alto, CA). The suspension was filled into self constructed migration chambers, which consisted of a microscopic glass slide, wax walls, and a cover slip on top. After polymerization of the collagen at 37°C in a humidified 5% CO2 atmosphere, concerning the leukocytes, the remaining chamber volume was filled with medium containing the investigated substances (medium conditioned with substances released by normoxic or hypoxic PC-3 cells), or, concerning the SH-SY5Y cells a second collagen matrix was applied next to the first one in the same manner as described above. This second collagen matrix contained 8 × 104 PC-3 cells. The migration of the cells was recorded by time-lapse videomicroscopy for 1 hour (leukocytes) or for 15 hours (SH-SY5Y and PC-3 cells) at 37°C. The paths of 30 randomly selected cells were digitized by computer-assisted cell tracking and the part of migratory active cells was calculated for each one minute or 15 minute interval. Statistically significant changes were calculated from the mean migratory activities in the steady state phase using the unpaired and undirected Student's t test; p-value lower than 0.05 was regarded as statistically significant.
Gene expression profiling
In order to analyze changes of the gene expression in PC-3 cells in response to SH-SY5Y cells, these cells were co-cultured without having direct cell-cell contact. For these experiments cell culture inserts for 6-well plates were used (8.0 μm pore size; Becton Dickinson, Le Pont De Claix, France). PC-3 cells (5 × 105) were cultured in the bottom of the 12-well plates, and SH-SY5Y cells (2 × 105) were cultured in the inserts. Empty inserts served as control. After 24 hours incubation, the total RNA of the PC-3 cells was isolated using a NucleoSpin RNA II kit (Machery&Nagel, Dueren, Germany). Real-time analysis of the gene expression of PC-3 cells (1 μg RNA per sample) was performed using the RT2 Profiler PCR Array System (SABiosciences, Frederick, MD) according to the manufacturer's protocol and an Abi Prism 7700 Sequence Detector (Applied Biosystems, Weiterstadt, Germany). Gene sets of the human growth factor kit and the human tumor metastasis kit were used.
The lytic activity of CTLs was analyzed by a colorimetric, non-radioactive cytotoxicity assay (Promega, Mannheim, Germany), which quantitatively measures the release of lactate dehydrogenase (LDH) after cell lysis according to Jurisic et al. , and as described previously . K562 human myeloid leukemia cells (DSMZ, Braunschweig, Germany) were used as target cells. In the assay, the PC-3 cell culture supernatants were added to the CTLs immediately before incubation with target cells. Non-conditioned medium served as control. The effectors were used at an effector:target ratio of 10:1. Cells were co-incubated for 4 h at 37°C, the supernatants were collected and the LDH release was evaluated by a colorimetric reaction (absorbance at 490 nm). The percentage of lysis was calculated by comparing the LDH released for each lysis condition maximal LDH release.
Effects of signal substances derived from PC-3 cells on SH-SY5Y neuroblastoma cells
Effects of signal substances from PC-3 cells on leukocytes
An important skill of cells that are involved in wound healing and inflammation is the ability to migrate. Leukocytes have to enter these wounded or inflamed sites from the blood stream by passing the vascular endothelial cells in order to eliminate pathogens and fully accomplish this tissue's functionality. As mentioned above, leukocytes are frequently found in tumors. Neutrophil granulocytes and macrophages can make up to 50 percent of the total tumor mass in breast carcinoma , and neutrophil granulocytes are supposed to play a role in inflammation-induced angiogenesis [19, 20].
It would be of course of interest, if in a more complex setting the mutual interaction of SH-SY5Y cells with PC-3 cells might also affect the function of the leukocytes. However, such experiments were started but brought no definite result so far. As one can understand, this is largely based on the fact, that we can treat either cell type (SH-SY5Y cells or PC-3 cells) with culture medium of the other cell type, respectively, but we can subsequently not separate the substances released by these two cell types. Therefore, we have always a mixed effect on the leukocytes with high variations and have thus abandoned from presenting results on this.
Although it is currently a focus in cancer research, how hypoxia changes the profile of expressed and released signal substances, especially with regard to neoangiogenesis [21–23], it is frequently reported that tumor cells release several signal substances even under normoxic conditions either constitutively or in response to other stimuli than hypoxia [24–27] including substances that have especially impact on nerve cells . We show herein that the PC-3 cells change the expression profile of signal substances not only in response to hypoxia, as reported previously , but also in response to other cells such as the nerve-like SH-SY5Y cells. Such a mutual exchange of signals might facilitate the innervation of the tumor. Our gene expression analysis has shown that several FGFs are expressed, which are known to be involved at least in neoangiogenesis and lymphangiogenesis [29, 30]. As documented before, these two processes have a common regulation with neoneurogenesis , and we thus argue that the nerve cells themselves contribute to the regulation of tumor innervation. It has been shown before that tumors release neurotrophic factors [31–33], and the presence of neuroendocrine markers in tumors is correlated with a poor prognosis in colorectal cancer [34, 35]. It is noteworthy that the neurotransmitter norepinephrine strongly enhances the migratory activity of PC-3 cells , and leads to an increased metastasis development in mice . Furthermore, prostate cancer cells invade and spread along nerve fibres, a process known as perineural invasion, which is correlated with a worse outcome in patients [38, 39]. Therefore, the innervation of a tumor might support tumor progression by the release of promigratory neurotransmitters such as norepinephrine and the guidance of cells away from the primary tumor. However, one final note is that the SH-SY5Y not constitutively release substances that induce migration of PC-3 cells, as shown in Fig. 5A.
As written above, tumors are often described as wounds that do not heal . In contrast, tumors may induce immune dysfunction , e.g. by the release of immunosuppressive substances such as interleukin-10 , or by an active counter-attack that induces apoptosis in the tumor-infiltrating leukocytes . In addition to the above discussed induction of metastasis formation, the innervation of tumors might support a proinflammatory milieu by the release of the according neurotransmitters. For example, peptidergic nerve fibres have been found in esophageal and cardiac carcinoma . In that study, substantial amounts of substance P have been found, which is a key mediator of inflammatory processes .
With regard to the interaction of the PC-3 cells with leukocytes, the substances released by the tumor cells do not provide a clear picture that points either to an inflammation-like immune stimulation or a to tumor-promoting immunosuppression in terms of a tumor escape mechanism. The expression of interleukin-10 is reduced in the presence of SH-SY5Y cells, whereas the expression of interleukin-1β is increased (Fig. 1). As reported previously, the expression of both interleukin-1α and β was enhanced under hypoxic conditions, too .
In terms of the leukocyte function, the migration of neutrophil granulocytes, but not of CTLs was stimulated solely by hypoxic PC-3 cell culture supernatant, whereas the normoxic cell culture supernatant has no effect on either cell type. This would be a sign of a rather inflammatory milieu, but in contrast, such a hypoxic milieu reduces the cytotoxicity of CTLs, which is simulated by the normoxic cell culture supernatant. However, a large number of substances that are released by the PC-3 cells have been described to modulate the function of immune cells, either alone or in combination. We are thus not able to attribute the observed effects to one single substance or a close circle of these substances. For example, the increase of interleukin-1β release in response to SH-SY5Y cells or hypoxia might explain the increase in the migratory activity of neutrophil granulocytes , but even other ligands whose expression has not been investigated here, might be responsible for this effect.
Finally, concerning the tumor cells themselves, there are some lines of evidence that the cells stimulate their migratory activity in an autocrine manner [46–49], including interleukin-1α and β , as well as FGF-5 , which are released by the PC-3 cells, too. Although the migratory activity of PC-3 cells significantly increases under hypoxic conditions, this is not due to such an autocrine effect (Fig.3B). In contrast, the substances released by hypoxic PC-3 cells slightly reduce the migratory activity of normoxic cells. Thus, hypoxia or its mediator, the transcription factor HIF (hypoxia inducible factor), directly activate an intracellular signalling pathway in the PC-3 cells, which induces migratory activity independent of an autocrine action of the released signal substances. In a broader view, this increase of migratory is important with regard to anti-angiogenic or angiostatic cancer treatment. Such treatments have been implemented in therapy protocols in order to cut off the tumor from nutrients and thereby stop its growth or ultimately provoke cell death. However, there is an increasing number of publications that report about an aggravation of the course of the cancer disease with respect to metastasis formation by the use of such therapeutics, and in light of these reports anti-angiogenesis has maybe to be revisited . The herein presented stimulation of migratory activity by oxygen deprivation might deliver an explanation for these evil side-effects of anti-angiogenic drugs.
It is well established that a growing tumor interacts with its microenvironment in order to accomplish nutrient supply, disposal of metabolites, and innervation. In this regard, a tumor behaves like any physiologically growing tissue. However, it still remains obscure, how these substances that are released by tumor cells in concert trigger an immune response. Hypotheses generally point to an inflammatory situation in tumors. Our results show that the signal substances released by PC-3 human prostate carcinoma cells have the potential to stimulate the innervation of a tumor, and that various leukocyte functions are affected. However, we have not seen a clear picture towards a proinflammatory process. Our functional investigations rather provide a chaotic picture with regard to the regulation of the immune system, which supports a view of a tumor escape by immune dysregulation.
We thank Gaby Troost for excellent technical assistance, and Mischa F. Möller for assistance with regard to the leukocyte migration experiments. This work was supported by the Fritz Bender Foundation (Munich, Germany).
- Folkman J, Merler E, Abernathy C, Williams G: Isolation of a tumor factor responsible for angiogenesis. J Exp Med. 1971, 133 (2): 275-288. 10.1084/jem.133.2.275.PubMed CentralView ArticlePubMedGoogle Scholar
- Orellana C: Is lymphangiogenesis as important as angiogenesis?. Lancet Oncol. 2005, 6 (5): 265-10.1016/S1470-2045(05)70153-4.View ArticlePubMedGoogle Scholar
- Entschladen F, Palm D, Drell TL, Lang K, Zaenker KS: Connecting a tumor to the environment. Curr Pharm Des. 2007, 13 (33): 3440-3444. 10.2174/138161207782360546.View ArticlePubMedGoogle Scholar
- Entschladen F, Palm D, Lang K, Drell TL, Zaenker KS: Neoneurogenesis: tumors may initiate their own innervation by the release of neurotrophic factors in analogy to lymphangiogenesis and neoangiogenesis. Med Hypotheses. 2006, 67 (1): 33-35. 10.1016/j.mehy.2006.01.015.View ArticlePubMedGoogle Scholar
- Dvorak HF, Flier J, Frank H: Tumors - wounds that do not heal - similarities between tumor stroma generation and wound-healing. N Engl J Med. 1986, 315 (26): 1650-1659.View ArticlePubMedGoogle Scholar
- Balkwill F, Mantovani A: Inflammation and cancer: back to Virchow?. Lancet. 2001, 357 (9255): 539-545. 10.1016/S0140-6736(00)04046-0.View ArticlePubMedGoogle Scholar
- Riehl A, Nemeth J, Angel P, Hess J: The receptor RAGE: Bridging inflammation and cancer. Cell Commun Signal. 2009, 7: 12-10.1186/1478-811X-7-12.PubMed CentralView ArticlePubMedGoogle Scholar
- Mantovani A, Allavena P, Sica A, Balkwill F: Cancer-related inflammation. Nature. 2008, 454 (7203): 436-444. 10.1038/nature07205.View ArticlePubMedGoogle Scholar
- Entschladen F, Drell TL, Lang K, Joseph J, Zaenker KS: Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. Lancet Oncol. 2004, 5 (4): 254-258. 10.1016/S1470-2045(04)01431-7.View ArticlePubMedGoogle Scholar
- Sheu BC, Chang WC, Cheng CY, Lin HH, Chang DY, Huang SC: Cytokine regulation networks in the cancer microenvironment. Front Biosci. 2008, 13: 6255-6268. 10.2741/3152.View ArticlePubMedGoogle Scholar
- Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003, 3 (10): 721-732. 10.1038/nrc1187.View ArticlePubMedGoogle Scholar
- Bastian P, Lang K, Niggemann B, Zaenker KS, Entschladen F: Myosin regulation in the migration of tumor cells and leukocytes within a three-dimensional collagen matrix. Cell Mol Life Sci. 2005, 62 (1): 65-76. 10.1007/s00018-004-4391-6.View ArticlePubMedGoogle Scholar
- Strell C, Sievers A, Bastian P, Lang K, Niggemann B, Zanker KS, Entschladen F: Divergent effects of norepinephrine, dopamine and substance P on the activation, differentiation and effector functions of human cytotoxic T lymphocytes. BMC Immunol. 2009, 10: 62-10.1186/1471-2172-10-62.PubMed CentralView ArticlePubMedGoogle Scholar
- Jurisic V, Spuzic I, Konjevic G: A comparison of the NK cell cytotoxicity with effects of TNF-alpha against K-562 cells, determined by LDH release assay. Cancer Lett. 1999, 138 (1-2): 67-72. 10.1016/S0304-3835(99)00011-7.View ArticlePubMedGoogle Scholar
- Lang K, Drell TL, Niggemann B, Zanker KS, Entschladen F: Neurotransmitters regulate the migration and cytotoxicity in natural killer cells. Immunol Lett. 2003, 90 (2-3): 165-172. 10.1016/j.imlet.2003.09.004.View ArticlePubMedGoogle Scholar
- Entschladen F, Palm D, Niggemann B, Zaenker KS: The cancer's nervous tooth: Considering the neuronal crosstalk within tumors. Semin Cancer Biol. 2008, 18 (3): 171-175. 10.1016/j.semcancer.2007.12.004.View ArticlePubMedGoogle Scholar
- Voss MJ, Niggemann B, Zaenker KS, Entschladen F: Tumor reactions to hypoxia. Curr Mol Med. 2010, 10 (4): 381-386. 10.2174/156652410791317020.View ArticlePubMedGoogle Scholar
- Queen MM, Ryan RE, Holzer RG, Keller-Peck CR, Jorcyk CL: Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res. 2005, 65 (19): 8896-8904. 10.1158/0008-5472.CAN-05-1734.View ArticlePubMedGoogle Scholar
- Benelli R, Albini A, Noonan D: Neutrophils and angiogenesis: potential initiators of the angiogenic cascade. Chem Immunol Allergy. 2003, 83: 167-181. full_text.View ArticlePubMedGoogle Scholar
- Gong Y, Koh DR: Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model. Cell Tissue Res. 2009, 339 (2): 437-438. 10.1007/s00441-009-0908-5.View ArticlePubMedGoogle Scholar
- Carmeliet P: VEGF as a key mediator of angiogenesis in cancer. Oncology. 2005, 69 (3): 4-10. 10.1159/000088478.View ArticlePubMedGoogle Scholar
- Semenza GL: Hypoxia-inducible factor 1 and cancer pathogenesis. IUBMB Life. 2008, 60 (9): 591-597. 10.1002/iub.93.View ArticlePubMedGoogle Scholar
- Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983, 219 (4587): 983-985. 10.1126/science.6823562.View ArticlePubMedGoogle Scholar
- Abruzzo LV, Thornton AJ, Liebert M, Grossman HB, Evanoff H, Westwick J, Strieter RM, Kunkel SL: Cytokine-induced gene expression of interleukin-8 in human transitional cell carcinomas and renal cell carcinomas. Am J Pathol. 1992, 140 (2): 365-373.PubMed CentralPubMedGoogle Scholar
- Fong CJ, Sherwood ER, Braun EJ, Berg LA, Lee C, Kozlowski JM: Regulation of prostatic carcinoma cell proliferation and secretory activity by extracellular matrix and stromal secretions. Prostate. 1992, 21 (2): 121-131. 10.1002/pros.2990210205.View ArticlePubMedGoogle Scholar
- Marjon PL, Bobrovnikova-Marjon EV, Abcouwer SF: Expression of the pro-angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 by human breast carcinomas is responsive to nutrient deprivation and endoplasmic reticulum stress. Mol Cancer. 2004, 3 (4):Google Scholar
- Thomas R, Kim MH: A HIF-1alpha-dependent autocrine feedback loop promotes survival of serum-deprived prostate cancer cells. Prostate. 2009, 69 (3): 263-275. 10.1002/pros.20885.View ArticlePubMedGoogle Scholar
- Chedotal A, Kerjan G, Moreau-Fauvarque C: The brain within the tumor: new roles for axon guidance molecules in cancers. Cell Death Differ. 2005, 12 (8): 1044-1056. 10.1038/sj.cdd.4401707.View ArticlePubMedGoogle Scholar
- Liersch R, Detmar M: Lymphangiogenesis in development and disease. Thromb Haemost. 2007, 98 (2): 304-310.PubMedGoogle Scholar
- Nissen LJ, Cao R, Hedlund EM, Wang Z, Zhao X, Wetterskog D, Funa K, Brakenhielm E, Cao Y: Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J Clin Invest. 2007, 117 (10): 2766-2777. 10.1172/JCI32479.PubMed CentralView ArticlePubMedGoogle Scholar
- Dolle L, Oliveira MJ, Bruyneel E, Hondermarck H, Bracke M: Nerve growth factor mediates its pro-invasive effect in parallel with the release of a soluble E-cadherin fragment from breast cancer MCF-7/AZ cells. J Dairy Res. 2005, 72 (Spec No): 20-26. 10.1017/S0022029905001160.View ArticlePubMedGoogle Scholar
- Ketterer K, Rao S, Friess H, Weiss J, Buchler MW, Korc M: Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer. Clin Cancer Res. 2003, 9 (14): 5127-5136.PubMedGoogle Scholar
- Ricci A, Greco S, Mariotta S, Felici L, Bronzetti E, Cavazzana A, Cardillo G, Amenta F, Bisetti A, Barbolini G: Neurotrophins and neurotrophin receptors in human lung cancer. Am J Respir Cell Mol Biol. 2001, 25 (4): 439-446.View ArticlePubMedGoogle Scholar
- Grabowski P, Maaser K, Hanski C, Stein H, Sturm I, Hopfenmuller W, Dorken B, Buhr HJ, Zeitz M, Scherubl H: Prognostic value of multimarker analysis in stage III colorectal cancer: one step forward towards an individualized therapy decision. Onkologie. 2005, 28 (8-9): 399-403. 10.1159/000086514.View ArticlePubMedGoogle Scholar
- Grabowski P, Scherubl H: Expression of neuroendocrine markers in undifferentiated carcinomas of the gastrointestinal tract. J Clin Oncol. 2005, 23 (21): 4795-4796. 10.1200/JCO.2005.05.218. author reply 4796-4797View ArticlePubMedGoogle Scholar
- Lang K, Drell TL, Lindecke A, Niggemann B, Kaltschmidt C, Zaenker KS, Entschladen F: Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer. 2004, 112 (2): 231-238. 10.1002/ijc.20410.View ArticlePubMedGoogle Scholar
- Palm D, Lang K, Niggemann B, Drell TL, Masur K, Zaenker KS, Entschladen F: The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int J Cancer. 2006, 118 (11): 2744-2749. 10.1002/ijc.21723.View ArticlePubMedGoogle Scholar
- Jeon HG, Bae J, Yi JS, Hwang IS, Lee SE, Lee E: Perineural invasion is a prognostic factor for biochemical failure after radical prostatectomy. Int J Urol. 2009, 16 (8): 682-686. 10.1111/j.1442-2042.2009.02331.x.View ArticlePubMedGoogle Scholar
- Liebig C, Ayala G, Wilks JA, Berger DH, Albo D: Perineural invasion in cancer: a review of the literature. Cancer. 2009, 115 (15): 3379-3391. 10.1002/cncr.24396.View ArticlePubMedGoogle Scholar
- Kiessling R, Wasserman K, Horiguchi S, Kono K, Sjoberg J, Pisa P, Petersson M: Tumor-induced immune dysfunction. Cancer Immunol Immunother. 1999, 48 (7): 353-362. 10.1007/s002620050586.View ArticlePubMedGoogle Scholar
- Pisa P, Halapi E, Pisa EK, Gerdin E, Hising C, Bucht A, Gerdin B, Kiessling R: Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA. 1992, 89 (16): 7708-7712. 10.1073/pnas.89.16.7708.PubMed CentralView ArticlePubMedGoogle Scholar
- Lang K, Entschladen F, Weidt C, Zaenker KS: Tumor immune escape mechanisms: impact of the neuroendocrine system. Cancer Immunol Immunother. 2006, 55 (7): 749-760. 10.1007/s00262-006-0126-x.View ArticlePubMedGoogle Scholar
- Lu SH, Zhou Y, Que HP, Liu SJ: Peptidergic innervation of human esophageal and cardiac carcinoma. World J Gastroenterol. 2003, 9 (3): 399-403.PubMed CentralView ArticlePubMedGoogle Scholar
- Bozic CR, Lu B, Hopken UE, Gerard C, Gerard NP: Neurogenic amplification of immune complex inflammation. Science. 1996, 273 (5282): 1722-1725. 10.1126/science.273.5282.1722.View ArticlePubMedGoogle Scholar
- Oliveira SH, Canetti C, Ribeiro RA, Cunha FQ: Neutrophil migration induced by IL-1beta depends upon LTB4 released by macrophages and upon TNF-alpha and IL-1beta released by mast cells. Inflammation. 2008, 31 (1): 36-46. 10.1007/s10753-007-9047-x.View ArticlePubMedGoogle Scholar
- Lang K, Niggemann B, Zanker KS, Entschladen F: Signal processing in migrating T24 human bladder carcinoma cells: role of the autocrine interleukin-8 loop. Int J Cancer. 2002, 99 (5): 673-680. 10.1002/ijc.10424.View ArticlePubMedGoogle Scholar
- Seton-Rogers SE, Lu Y, Hines LM, Koundinya M, LaBaer J, Muthuswamy SK, Brugge JS: Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells. Proc Natl Acad Sci USA. 2004, 101 (5): 1257-1262. 10.1073/pnas.0308090100.PubMed CentralView ArticlePubMedGoogle Scholar
- Silletti S, Paku S, Raz A: Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells. Am J Pathol. 1996, 148 (5): 1649-1660.PubMed CentralPubMedGoogle Scholar
- Chedotal A: Chemotropic axon guidance molecules in tumorigenesis. Prog Exp Tumor Res. 2007, 39: 78-90. full_text.View ArticlePubMedGoogle Scholar
- Verhasselt B, Van Damme J, van Larebeke N, Put W, Bracke M, De Potter C, Mareel M: Interleukin-1 is a motility factor for human breast carcinoma cells in vitro: additive effect with interleukin-6. Eur J Cell Biol. 1992, 59 (2): 449-457.PubMedGoogle Scholar
- Allerstorfer S, Sonvilla G, Fischer H, Spiegl-Kreinecker S, Gauglhofer C, Setinek U, Czech T, Marosi C, Buchroithner J, Pichler J, Silye R, Mohr T, Holzmann K, Grasl-Kraupp B, Marian B, Grusch M, Fischer J, Micksche M, Berger W: FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities. Oncogene. 2008, 27 (30): 4180-4190. 10.1038/onc.2008.61.PubMed CentralView ArticlePubMedGoogle Scholar
- Loges S, Mazzone M, Hohensinner P, Carmeliet P: Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited. Cancer Cell. 2009, 15 (3): 167-170. 10.1016/j.ccr.2009.02.007.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.